Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide dose-ranging study in pediatric functional constipation
NCT02559570Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2015
- Primary completion
- Apr 2018
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of linaclotide in functional constipation (FC), sponsored by Forest Laboratories. Started Nov 2015; status: completed.
02
Drugs
linaclotide
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT02559570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559570.